Athira Pharma, Inc. (ATHA) Reports In-Line Q2 EPS

Athira Pharma, Inc. (NASDAQ: ATHA) reported Q2 EPS of ($0.78), in-line with the analyst estimate of ($0.78).

For earnings history and earnings-related data on Athira Pharma, Inc. (ATHA) click here.

You May Also Be Interested In

• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• Kite Realty sells City Center in White Plains for $50 million
• Apogee Enterprises (APOG) Tops Q1 EPS by 16c, Beats on Revenue; Offers FY27 Guidance